openPR Logo
Press release

SMi Group interviews SKAN AG's Richard Denk for the upcoming Highly Potent Active Pharmaceutical Ingredients conference in May.

03-04-2020 10:11 AM CET | Health & Medicine

Press release from: SMi Group

HPAPI

HPAPI

The 4th annual Highly Potent Active Pharmaceutical Ingredients conference will take place on the 11th - 12th May in London. The event will involve key profiles from leading pharma organisations to meet and discuss HPAPI manufacturing, where delegates will gain a better understanding of the oncology market and ADC production which is one of the main forces in the HPAPI industry.

The two-day conference will also explore the challenges in the industry, such as determining toxicology limits, assessing hazards, implementing risk procures, translating risk assessment into facility engineering, preventing and dealing with cross-contamination and adhering to GMP regulatory guidelines.

Ahead of the conference, SMi caught up with SKAN AG's Senior Consultant, Aseptic Processing & Containment Richard Denk, to review his insights on how the HPAPI market is developing, the importance of the 2020 conference, along with containment issues and challenges.

Snapshot of Richard's interview:

In your opinion, what are the current market drivers of the HPAPI industry?

"BioPharmaceuticals, Oral Solid Dosage Forms, API`s and the development of new novel medicines are one driver for the HPAPI Industry other drivers are regulatory requirements from the EMA. Since the exposure limits for use in risk identification in the EMA published the Guideline on setting health manufacture of different medicinal products in shared facilities, every product requires a PDE "Permitted Daily Exposure" and is calculated by experts. Beside Occupational Safety Requirements, GMP Requirements now also drive the expansion of Containment solutions".

As a containment expert, what would you say is the importance of a meeting on Highly Potent APIs? What major issues would you say are important to discuss in 2020?

"There are several important topics to cover in 2020. Within containment, for 20+ years we have been discussing protecting the operators from the hazardous substance. As a result, a lot of Containment Solutions and Transfer Systems are developed and many of them are successfully in use. Almost all of them have one common challenge that the operator has to get close to, the Containment connection of the hazardous substance. This could be for example on a flexible bag solution where the operator has to do some manipulation to make the Containment work. As one of the topics I`d like to highlight automation of containment for keeping the operator away from the hazardous substance..."

There will also be 2 interactive half-day post-conference workshop held by Justin Mason-Home, Director, HPAPI Project Services Limited, on the 13th of May to focus on "Practical Steps for Delivering HPAPI Projects." as well as David Embrey, Managing Director, Human Reliability Ltd. On "A roadmap to enhancing organisational safety in HPAPI manufacturing: A Human factors perspective".

For the full interview, speaker line-up and more information on the conference and registration, visit: http://www.highlypotentapi.com/openpr4

--- END ---

Highly Potent Active Pharmaceutical Ingredients
Main conference: 11th-12th May 2020
Post-conference workshop day: 13th May 2020
London, UK
Proudly sponsored by: BSP Pharmaceuticals
Exhibitor: Dec Group

To sponsor or exhibit at the conference, please contact Alia Malick on +44 (0) 207 827 6748 or amalick@smi-online.co.uk.

For all delegate enquiries, contact Dylan Brohm on +44 (0) 20 7827 1024 or dbrohm@smi-online.co.uk.

Ground Floor, India House, 45 Curlew Street

About SMi Group:
Established since 1993, the SMi Group is a global event-production company that specializes in Business-to-Business Conferences, Workshops, Masterclasses and online Communities. We create and deliver events in the Defence, Security, Energy, Utilities, Finance and Pharmaceutical industries. We pride ourselves on having access to the world's most forward-thinking opinion leaders and visionaries, allowing us to bring our communities together to Learn, Engage, Share and Network. More information can be found at http://www.smi-online.co.uk

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release SMi Group interviews SKAN AG's Richard Denk for the upcoming Highly Potent Active Pharmaceutical Ingredients conference in May. here

News-ID: 1953797 • Views: 190

More Releases from SMi Group

Registration is open for SMi's 2nd Annual Next Generation Pharmaceutical Cleanro …
SMi Reports: The 2nd Annual Next Generation Pharmaceutical Cleanroom Conference will convene in London on 7th - 8th October 2020. Following on from the success of last years inaugural conference, SMi Group proudly presents the 2nd Annual Next Generation Pharmaceutical Cleanroom Conference, taking place in London, UK on the 7 - 8 October 2020. Chaired by Matts Ramstorp, CEO & Founder, BioTekPro, the 2-day conference will look into the influence of the
Small Satellites 2020 To Discuss Legal Frameworks for Satellite and Spectrum Man …
Small Satellites 2020 To Discuss Legal Frameworks for Satellite and Spectrum Management On 1st - 2nd September 2020, a host of military, space agencies, regulators and industry professionals will convene in London to discuss the growing importance of the small satellite industry. As the number of players entering the small, nano and cube satellite markets increases, it is becoming crucial to consider best practice and regulations for operating in space. As such,
US Space Force and L3Harris To Attend Military Space Situational Awareness 2020
SMi reports: US Space Force and L3 Harris will be attending the Military Space Situational Awareness conference in London on the 3rd and 4th September 2020. The US Space Force's Space and Missile Systems Center has awarded L3 Harris a 10-year $1.2 billion contract to provide operations, maintenance and space situational awareness to the US military's space surveillance and command centres across the country, in line with a new programme called
Lockheed Martin and BAE Systems to Present Technical Briefings at Future Armoure …
SMi Reports: Future Armoured Vehicles Systems 2020 will be held as a virtual conference, and will feature technical briefings from industry experts including BAE Systems and Lockheed Martin Last month, SMi Group made the decision to transform Future Armoured Vehicles Weapon Systems from an in-person event to one that's 100% digital. Set to occur remotely on 3rd-4th June 2020, the conference will provide a flexible, innovative way to explore the latest technologies,

All 5 Releases


More Releases for HPAPI

Global High Performance Active Pharmaceutical Ingredients (HPAPI) Market Researc …
This report studies the global High Performance Active Pharmaceutical Ingredients (HPAPI) market status and forecast, categorizes the global High Performance Active Pharmaceutical Ingredients (HPAPI) market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in North America, Europe, Japan, China, and other regions (India, Southeast Asia). The major manufacturers covered in this report Bristol-Myers Squibb Novartis Sanofi Aventis Pfizer Lonza Novasep Hospira
HPAPI 2019 Conference: Exclusive Interview Released with AstraZeneca
Peter Marshall from AstraZeneca will be speaking at SMi’s 3rd Annual Highly Potent Active Pharmaceutical Ingredients (HPAPI) Conference which will take place in London on 13th-14th May. He will be discussing the latest developments in the industry with a specific focus on the principles of pharmaceutical containment in isolator design. Ahead of the conference, SMi had interviewed him where he gave a taster of what he will be discussing. Peter said: “The
The Latest Techniques in HPAPI Facility Design
Amongst the myriad of potential pitfalls for the Highly Potential Active Pharmaceutical Ingredients (HPAPI) industry there is a requirement for all parties involved to have a blueprint in place to ensure all containment procedures are followed correctly. Yet, there is also a need to ensure that operations are maintained at the highest standards. At SMi’s 3rd Annual Highly Potent Active Pharmaceutical Ingredients Conference these issues will be discussed along with
HPAPI (High Potency Active Pharmaceutical Ingredients) Market Report 2018: Segme …
Global HPAPI (High Potency Active Pharmaceutical Ingredients) market research report provides company profile for Lonza, Novasep, Thermofisher Scientific, Alkermes, Cambrex, Dishman, Dr. Reddy’S and Others. This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth rate, and CAGR for the year 2018 to 2025, etc. The report
SMi’s HPAPI 2018 Conference: Exclusive Interview Released with HPAPI Project S …
SMi are delighted to have our Chairman, Speaker and Workshop Host, Justin Mason-Home, Director, HPAPI Project Services Limited, onto the speaker panel for HPAPI 2018! About Justin: Justin Mason-Home is an organic chemist with extensive health, safety, environmental and chemical engineering experience in senior technical, legal and commercial aspects of the pharmaceutical, biochemical, chemical and other industries. He has held senior positions and worked globally in potent biopharmaceutical occupational health and safety
Exclusive Interview Released with HPAPI Project Services
SMi are delighted to have our Chairman, Speaker and Workshop Host, Justin Mason-Home, Director, HPAPI Project Services Limited, onto the speaker panel for HPAPI 2018! About Justin: Justin Mason-Home is an organic chemist with extensive health, safety, environmental and chemical engineering experience in senior technical, legal and commercial aspects of the pharmaceutical, biochemical, chemical and other industries. He has held senior positions and worked globally in potent biopharmaceutical occupational health and safety